JP2017523142A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017523142A5 JP2017523142A5 JP2016572533A JP2016572533A JP2017523142A5 JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5 JP 2016572533 A JP2016572533 A JP 2016572533A JP 2016572533 A JP2016572533 A JP 2016572533A JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- range
- surfactant
- macrogol
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3077CH2014 | 2014-06-25 | ||
| IN3077/CHE/2014 | 2014-06-25 | ||
| PCT/IN2015/000266 WO2015198350A1 (en) | 2014-06-25 | 2015-06-25 | A pharmaceutical oil-in-water nano-emulsion |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019189623A Division JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017523142A JP2017523142A (ja) | 2017-08-17 |
| JP2017523142A5 true JP2017523142A5 (OSRAM) | 2018-07-05 |
| JP6634034B2 JP6634034B2 (ja) | 2020-01-22 |
Family
ID=54015153
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572533A Expired - Fee Related JP6634034B2 (ja) | 2014-06-25 | 2015-06-25 | 医薬水中油型ナノエマルジョン |
| JP2019189623A Pending JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019189623A Pending JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10736842B2 (OSRAM) |
| EP (1) | EP3160444B1 (OSRAM) |
| JP (2) | JP6634034B2 (OSRAM) |
| WO (1) | WO2015198350A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2393768T3 (es) | 2005-05-26 | 2012-12-27 | Neuron Systems, Inc | Derivado de quinolina para el tratamiento de enfermedades retinianas |
| WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
| CN117045653A (zh) | 2013-01-23 | 2023-11-14 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US11400048B2 (en) * | 2014-06-25 | 2022-08-02 | Synergia Bio Sciences Private Limited | Pharmaceutical oil-in-water nano-emulsion |
| JP6947406B2 (ja) | 2015-08-21 | 2021-10-13 | アルデイラ セラピューティクス， インコーポレイテッド | 重水素化化合物およびその使用 |
| WO2017196881A1 (en) | 2016-05-09 | 2017-11-16 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
| CN109562065A (zh) * | 2016-06-07 | 2019-04-02 | 塔佳吉尼克斯公司 | 靶向癌细胞和癌干细胞的紫杉烷类药物的纳米乳剂组合物及其使用方法 |
| EP3534961A4 (en) | 2016-11-02 | 2020-05-27 | Centrexion Therapeutics Corporation | STABLE AQUEOUS INJECTABLE CAPSAICIN FORMULATIONS AND MEDICAL USES THEREOF |
| PL3558269T3 (pl) * | 2016-12-21 | 2024-11-18 | Dukebox Spółka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania emulsji woda w oleju nanocząsteczek paracetamolu |
| ES3018268T3 (en) | 2017-07-20 | 2025-05-14 | Centrexion Therapeutics Corp | Compositions and their use for treatment of pain using capsaicin |
| JP7311162B2 (ja) | 2017-10-10 | 2023-07-19 | アルデイラ セラピューティクス， インコーポレイテッド | 炎症性障害の処置 |
| US11278492B2 (en) * | 2018-01-05 | 2022-03-22 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device |
| JP7385881B2 (ja) * | 2018-07-18 | 2023-11-24 | テクノガード株式会社 | オキシカム系薬物含有注射剤 |
| US20200038392A1 (en) * | 2018-08-03 | 2020-02-06 | Aldeyra Therapeutics, Inc. | Topical compositions and methods of preparation and use |
| CN112714762A (zh) | 2018-08-06 | 2021-04-27 | 奥尔德拉医疗公司 | 多晶型化合物及其用途 |
| US12501929B2 (en) | 2018-08-22 | 2025-12-23 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| US11517685B2 (en) | 2019-01-18 | 2022-12-06 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| US11690963B2 (en) | 2018-08-22 | 2023-07-04 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| US20200060338A1 (en) | 2018-08-22 | 2020-02-27 | Respira Technologies, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| CN113365590A (zh) * | 2018-11-21 | 2021-09-07 | 博坎纳维达有限责任公司 | 透气带及其它产品中的经纳米乳化的大麻素或油 |
| US12472103B2 (en) | 2018-11-21 | 2025-11-18 | Bocannaveda, Llc | Nano-emulsified cannabinoid or oils in athletic tape and other products |
| GB201904771D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| EP3962894A4 (en) | 2019-05-02 | 2023-01-11 | Aldeyra Therapeutics, Inc. | POLYMORPHIC COMPOUNDS AND USES THEREOF |
| WO2020223717A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| CN114245737A (zh) | 2019-06-11 | 2022-03-25 | 司斐股份有限公司 | 微乳剂组合物 |
| US20210113783A1 (en) * | 2019-10-20 | 2021-04-22 | Respira Technologies, Inc. | Electronic devices and liquids for aerosolizing and inhaling therewith |
| TW202128132A (zh) * | 2019-10-20 | 2021-08-01 | 美商瑞斯比拉科技公司 | 使用電子裝置進行霧化及吸入之液體 |
| CA3175856A1 (en) | 2020-05-13 | 2021-11-18 | Todd Brady | Pharmaceutical formulations and uses thereof |
| US12471625B2 (en) | 2020-11-01 | 2025-11-18 | Qnovia, Inc. | Electronic devices and liquids for aerosolizing and inhaling therewith |
| EP4510873A1 (en) | 2022-04-22 | 2025-02-26 | Qnovia, Inc. | Electronic devices for aerosolizing and inhaling liquid |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646773B1 (fr) * | 1989-05-12 | 1994-05-13 | Chauvin Sa Laboratoire | Composition pharmaceutique a base de paracetamol |
| US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
| US5929070A (en) | 1996-03-25 | 1999-07-27 | Eli Lilly And Company | Method for treating migraine pain with olanzapine |
| CA2313024C (en) * | 1997-12-10 | 2008-06-03 | Severson, Mary L. | Pharmaceutical compositions containing an omega-3 fatty acid oil |
| AU3843999A (en) * | 1998-05-07 | 1999-11-23 | Elan Corporation, Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| GB9823246D0 (en) | 1998-10-24 | 1998-12-16 | Danbiosyst Uk | A nasal drug delivery composition |
| US20030044356A1 (en) * | 2001-04-20 | 2003-03-06 | Jin Auh | Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one) |
| GB0116107D0 (en) | 2001-06-30 | 2001-08-22 | West Pharm Serv Drug Res Ltd | Pharmaceutical composition |
| KR100425755B1 (ko) | 2001-08-27 | 2004-04-03 | 주식회사 원진신약 | 이트라코나졸을 함유하는 조성물 및 그 제조방법 |
| IL164163A0 (en) | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| US20060210500A1 (en) * | 2003-04-18 | 2006-09-21 | Merck Patent Gmbh | Formulations |
| IL181217A0 (en) * | 2007-02-08 | 2007-07-04 | Haim Levy | Pharmaceuticalcompositions based on a microemulsion |
| CN101524329B (zh) | 2007-09-20 | 2014-09-03 | 中国医学科学院药物研究所 | 双环醇亚微乳及其制备方法 |
| CN101780037B (zh) | 2010-02-03 | 2011-11-16 | 南昌大学 | 双嘧达莫自乳化给药系统及其制备方法 |
-
2015
- 2015-06-25 WO PCT/IN2015/000266 patent/WO2015198350A1/en not_active Ceased
- 2015-06-25 US US15/309,716 patent/US10736842B2/en active Active
- 2015-06-25 JP JP2016572533A patent/JP6634034B2/ja not_active Expired - Fee Related
- 2015-06-25 EP EP15757010.2A patent/EP3160444B1/en active Active
-
2019
- 2019-10-16 JP JP2019189623A patent/JP2020037557A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017523142A5 (OSRAM) | ||
| US11020375B2 (en) | Edaravone dosage form | |
| JP5726067B2 (ja) | 難透過性医薬品活性成分のための改善された製剤 | |
| JP2020037557A (ja) | 医薬水中油型ナノエマルジョン | |
| JP6670283B2 (ja) | タペンタドールを含む半固形の水性医薬組成物 | |
| EP3481381B1 (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
| JP2009514890A (ja) | テトラヒドロカンナビノールの改良された送達 | |
| TW200302734A (en) | Pharmaceutical compositions for hepatitis c viral protease inhibitors | |
| US20130171237A1 (en) | Aripiprazole compositions and methods for its transdermal delivery | |
| US20210346302A1 (en) | Pharmaceutical Formulation | |
| CN1543359A (zh) | 可生物利用的口服剂型醋氯芬酸组合物及其制备方法 | |
| US10973761B2 (en) | Pharmaceutical formulation | |
| TW200840596A (en) | Microemulsion dosage forms of valsartan and methods of making the same | |
| CN111465412A (zh) | Nk-1拮抗剂的口服药物组合物 | |
| CN106727382A (zh) | 一种卡维地洛过饱和自微乳分散片及其制备方法 | |
| JP5503939B2 (ja) | アゼラスチン塩酸塩含有カプセル剤 | |
| KR20250129103A (ko) | 자가유화 약학적 조성물, 그 제조 방법 및 그 용도 | |
| JP2017518980A (ja) | タペンタドールを含む、改変防止即時放出カプセル製剤 | |
| US20250032520A1 (en) | Oral cannabinoid compositions and methods for treating neurological diseases and disorders | |
| EP3135299A1 (en) | Active ingredient (i) containing composition and method for preparing same | |
| Pires et al. | Antipsychotics-loaded Nanometric emulsions for brain delivery. Pharmaceutics. 2022; 14: 2174 | |
| KR20190032265A (ko) | 약제학적 제형 | |
| TR2021012699A2 (tr) | Cannabi̇di̇olün nazal uygulanan kolloi̇dal formülasyonlari | |
| HK40008934A (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
| HK40008934B (en) | Oral dosage form with drug composition, barrier layer and drug layer |